Skip to content
The Policy VaultThe Policy Vault

Cresemba (isavuconazonium) — Point32Health

invasive aspergillosis

Initial criteria

  • Patient was started on Cresemba (isavuconazonium) in an inpatient setting OR
  • Diagnosis of invasive mucormycosis AND inadequate response, intolerance, or contraindication to posaconazole OR
  • Diagnosis of invasive aspergillosis AND inadequate response, intolerance, or contraindication to voriconazole